Alendronate Sodium
Product Images NDC 33261-554

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Alendronate Sodium (NDC 33261-554). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Alendronate Sodium 70mg Tab 4 Pck For Teva 1)

Chemical structure of Alendronate Sodium depicted with its molecular formula showing phosphonate groups and amine substituent. The structure includes three water molecules of hydration as part of the compound.*

FDA Label Image

Image Label (Alendronate Sodium 70mg Tab 4 Pck For Teva 10)

Label for Alendronate Sodium 70 mg tablets by Aidarex Pharmaceuticals LLC. The label indicates a package size of 4 tablets per pack (4/PCK). It includes active ingredient information, manufacturer details (Teva Pharmaceuticals USA, Sellersville, PA), and multiple references to NDC 33261-0554-01. The label also lists the generic name Fosamax.*

FDA Label Image

Figure 1 (Alendronate Sodium 70mg Tab 4 Pck For Teva 2)

A cumulative incidence line graph comparing Alendronate Sodium to Placebo over 36 months. The y-axis shows cumulative incidence percentage up to 10%, and the x-axis represents time in months from 0 to 36. Alendronate Sodium shows consistently lower cumulative incidence than Placebo throughout the period.*

FDA Label Image

Figure 2 (Alendronate Sodium 70mg Tab 4 Pck For Teva 3)

A bar chart comparing the percent increase in Bone Mineral Density (BMD) at three anatomical sites: Lumbar Spine, Femoral Neck, and Trochanter, between U.S. and Multinational groups. Bars indicate mean values with standard error.*

FDA Label Image

Figure 3 (Alendronate Sodium 70mg Tab 4 Pck For Teva 4)

Line graph depicting mean percent change in bone mineral density (BMD) from baseline over 36 months in a U.S. study. The graph compares Alendronate Sodium 10 mg to placebo, with BMD increasing steadily over time in the Alendronate Sodium group, while remaining near baseline for the placebo group. Error bars indicate standard error.*

FDA Label Image

Figure 3a (Alendronate Sodium 70mg Tab 4 Pck For Teva 5)

A line graph from a multinational study showing bone mineral density (BMD) mean percentage change from baseline over 36 months. It compares Alendronate Sodium 10 mg with placebo, indicating a higher increase in BMD for Alendronate Sodium across the duration compared to placebo, which remains near baseline.*

FDA Label Image

Figure 4 (Alendronate Sodium 70mg Tab 4 Pck For Teva 6)

A bar graph titled 'Change in BMD From Baseline 2 Year Study' comparing mean percent change in bone mineral density (BMD) with standard error for Alendronate Sodium 5 mg/day versus placebo. The graph shows results at four anatomical sites: Lumbar Spine, Femoral Neck, Trochanter, and Total Body, with Alendronate groups showing positive changes and placebo groups mostly negative or minimal changes in BMD.*

FDA Label Image

Figure 4a (Alendronate Sodium 70mg Tab 4 Pck For Teva 7)

A bar chart titled "Change in BMD From Baseline 3 Year Study" comparing mean percent change in bone mineral density (BMD) at four sites: Lumbar Spine, Femoral Neck, Trochanter, and Total Body. It contrasts Alendronate Sodium 5 mg/day treatment with placebo, showing positive BMD changes for Alendronate and negative changes for placebo across all sites.*

FDA Label Image

Figure 5 (Alendronate Sodium 70mg Tab 4 Pck For Teva 8)

A bar chart comparing mean percent change in bone mineral density (BMD) from baseline over a 2-year study for Alendronate Sodium 5 mg/day versus placebo at four sites: Lumbar Spine, Femoral Neck, Trochanter, and Total Body. Alendronate Sodium shows positive BMD changes, while placebo shows negative or minimal changes.*

FDA Label Image

Figure 6 (Alendronate Sodium 70mg Tab 4 Pck For Teva 9)

A line graph showing mean percent change from baseline in serum alkaline phosphatase over time (months) for four groups: Placebo, Etidronate 400 mg/day, Alendronate Sodium 40 mg/day from a multinational study, and Alendronate Sodium 40 mg/day from a U.S. study. Data points include error bars and sample sizes (N) are noted for each group at the final time point.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.